These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 30535856)

  • 1. [Clinical picture and diagnosis of neurotrophic keratopathy].
    Messmer EM
    Ophthalmologe; 2019 Feb; 116(2):120-126. PubMed ID: 30535856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotrophic keratopathy: An updated understanding.
    Neurotrophic Keratopathy Study Group
    Ocul Surf; 2023 Oct; 30():129-138. PubMed ID: 37666470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular basis of neurotrophic keratopathy: Diagnostic and therapeutic implications. A review.
    Ruiz-Lozano RE; Hernandez-Camarena JC; Loya-Garcia D; Merayo-Lloves J; Rodriguez-Garcia A
    Ocul Surf; 2021 Jan; 19():224-240. PubMed ID: 33022412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurotrophic keratopathy : Principles, diagnostics and treatment].
    Mergler S; Dietrich-Ntoukas T; Pleyer U
    Ophthalmologe; 2019 Aug; 116(8):797-810. PubMed ID: 31372724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenesis and epidemiology of neurotrophic keratopathy].
    Mertsch S; Alder J; Dua HS; Geerling G
    Ophthalmologe; 2019 Feb; 116(2):109-119. PubMed ID: 30478498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotrophic keratopathy.
    Dua HS; Said DG; Messmer EM; Rolando M; Benitez-Del-Castillo JM; Hossain PN; Shortt AJ; Geerling G; Nubile M; Figueiredo FC; Rauz S; Mastropasqua L; Rama P; Baudouin C
    Prog Retin Eye Res; 2018 Sep; 66():107-131. PubMed ID: 29698813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of neurotrophic keratopathy in combined lesions of the trigeminal and facial nerves].
    Gushchina MB; Butsan SB; Salikhov KS; Sergeeva VY
    Vestn Oftalmol; 2022; 138(3):102-109. PubMed ID: 35801888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotrophic keratopathy: current challenges and future prospects.
    NaPier E; Camacho M; McDevitt TF; Sweeney AR
    Ann Med; 2022 Dec; 54(1):666-673. PubMed ID: 35243932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advancements in corneal sensory reconstruction for the treatment of neurotrophic keratopathy].
    Su D; Zhang JY; Li J
    Zhonghua Yan Ke Za Zhi; 2023 Apr; 59(4):313-320. PubMed ID: 37012597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting Edge: Topical Recombinant Nerve Growth Factor for the Treatment of Neurotrophic Keratopathy-Biologicals as a Novel Therapy for Neurotrophic Keratopathy.
    Hamrah P; Yavuz Saricay L; Ozmen MC
    Cornea; 2022 Jun; 41(6):673-679. PubMed ID: 35266655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of neurotrophic keratopathy.
    Lambiase A; Rama P; Aloe L; Bonini S
    Curr Opin Ophthalmol; 1999 Aug; 10(4):270-6. PubMed ID: 10621535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotrophic Keratopathy in Pediatric Patients.
    Scelfo C; Mantagos IS
    Semin Ophthalmol; 2021 May; 36(4):289-295. PubMed ID: 33755526
    [No Abstract]   [Full Text] [Related]  

  • 13. Neurotrophic keratopathy.
    Pushker N; Dada T; Vajpayee RB; Gupta V; Aggrawal T; Titiyal JS
    CLAO J; 2001 Apr; 27(2):100-7. PubMed ID: 11352446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotrophic keratitis.
    Bonini S; Rama P; Olzi D; Lambiase A
    Eye (Lond); 2003 Nov; 17(8):989-95. PubMed ID: 14631406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of Neurotrophic Keratopathy and a Stage-Based Approach to Its Management.
    Safi M; Rose-Nussbaumer J
    Eye Contact Lens; 2021 Mar; 47(3):140-143. PubMed ID: 33208601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The cornea: stasis and dynamics].
    Nishida T
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):179-212; discussion 213. PubMed ID: 18411711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Human Nerve Growth Factor for Pediatric Neurotrophic Keratopathy.
    Niruthisard D; Fung SSM
    Eye Contact Lens; 2022 Jul; 48(7):303-305. PubMed ID: 35726907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current and experimental treatment approaches for neurotrophic keratopathy].
    Alder J; Mertsch S; Menzel-Severing J; Geerling G
    Ophthalmologe; 2019 Feb; 116(2):127-137. PubMed ID: 30707284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modern capabilities in diagnosis and treatment of neurotrophic keratopathy].
    Brzheskiy VV; Popov VY; Efimova EL; Golubev SY
    Vestn Oftalmol; 2022; 138(6):123-132. PubMed ID: 36573956
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.